Navigation Links
Biodel to Raise $9.4 Million Through Registered Direct Offering
Date:8/25/2010

DANBURY, Conn., Aug. 25 /PRNewswire-FirstCall/ -- Biodel Inc. (Nasdaq: BIOD) today announced that it has entered into definitive agreements with two institutional investors to sell 2,398,200 shares of its common stock and warrants to purchase 2,398,200 shares of its common stock.  The common stock and warrants are being sold as units, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock.  

The investors have agreed to purchase the units for a negotiated price of $3.93 per unit, resulting in gross proceeds to Biodel, before deducting placement agents' fees and estimated offering expenses, of approximately $9.4 million.  The offering is expected to close on or about August 30, 2010, subject to customary closing conditions.  Wedbush PacGrow Life Sciences, Leerink Swann LLC and William Blair & Company, L.L.C. acted as co-lead placement agents for the offering.  

The initial per share exercise price of the warrants is $4.716.  On the 21st trading day following the PDUFA date relating to the new drug application for Biodel's product candidate, VIAject®, the exercise price will be adjusted to 90% of the arithmetic average of the volume weighted average price of Biodel's common stock on each of the ten trading days prior to the 21st day following the PDUFA date.  In no event will the exercise price be greater than the initial per share exercise price of the warrants.  The warrants will be exercisable beginning on the original date of issuance and will expire on the date that is 12 months after the 21st day following the PDUFA date.  Biodel expects the PDUFA date to be October 30, 2010.

The securities described above are being offered by Biodel pursuant to a registration statement previously filed with and subsequently declared effective by the Securities and Excha
'/>"/>

SOURCE Biodel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Biodel Announces Schedule for Presentations at the 37th Annual Meeting and Exposition of the Controlled Release Society
2. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
3. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
4. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
5. StatRad Raises the Bar With Fully Integrated Teleradiology Solution
6. HemaQuest Pharmaceuticals Raises Additional $4M to Bring Total to $16M in Series B Financing
7. AVAC Praises CAPRISA 004 Trial Collaborators and Participants for Historic Study - Trial Confirms Promise of ARV-Based Microbicides
8. Zogenix Secures $35 Million Debt Facility and Raises $15 Million Investment Capital
9. Bacterin International Holdings, Inc. Completes Merger and $7.5 Million Raise
10. SynapDx Corporation Raises $9 Million in Series A Funding
11. NanoPowers Raises CHF 5 Million ($4.5 Million) in Series A Financing to Support Development of Breakthrough Urinary Incontinence Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Brazil Gynecological Devices Market ... GlobalData,s new report, "Brazil Gynecological Devices Market ... the Brazil Gynecological Devices market. The report provides ... units) and average prices (in US dollars) within ... Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips ...
(Date:9/17/2014)... , Sept. 17, 2014 The ... the last decade due to the recession, ... and technological advancements. This BCC Research report ... segments of the ambulance and emergency medical ... blood and hemorrhage control devices, equipment used ...
(Date:9/17/2014)... MONICA, Calif. , Sept. 17, 2014  Dr. ... is at the White House today for National Recovery ... 46 that consumer advocates released today. Consumer advocates were ... woman who spoke out after losing her fiancée ... discovering that the doctor had a history of crack ...
Breaking Medicine Technology:Brazil Gynecological Devices Market Outlook to 2020 2Brazil Gynecological Devices Market Outlook to 2020 3Ambulance and Emergency Equipment: Global Markets 2Ambulance and Emergency Equipment: Global Markets 3Ambulance and Emergency Equipment: Global Markets 4Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 2Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 3
... 26, 2011 Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX ... overview at the Jefferies 2011 Global Healthcare Conference on June ... The live and archived webcast of the company ... Idenix Investor Center at www.idenix.com . Please log in ...
... A new prostate cancer study published ... treatment to "watchful waiting" revealed important findings for ... debating their treatment options. (Photo:   http://photos.prnewswire.com/prnh/20110526/NY09899 ... clinical options for early prostate cancer treatment today ...
Cached Medicine Technology:Robotic Prostatectomy Expert Dr. David Samadi on a High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment 2Robotic Prostatectomy Expert Dr. David Samadi on a High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment 3
(Date:9/17/2014)... 2014 (HealthDay News) -- Social networking sites can help ... For people who are obese, sites like Twitter and ... support from doctors as well as peers, researchers found. ... methods is that it offers the potential to be ... when compared to traditional approaches," the study,s lead author, ...
(Date:9/17/2014)... September 17, 2014 The Oliver Law ... infections allegedly caused by Non-Sterile Other-Sonic Ultrasound Transmission ... about their options for legal recourse. Other-Sonic ultrasound gel ... (FDA) in March 2012, after the product was linked ... William Beaumont Hospital in Royal Oak, Michigan . While ...
(Date:9/17/2014)... 2014 Catalent Pharma Solutions, the ... development solutions for drugs, biologics and consumer health ... integrated service and technology offer based on the ... the company’s 450,000 sq. ft. Kansas City, MO ... integrate optimal formulation, development, analytical expertise, scale up ...
(Date:9/17/2014)... -- A blood test that measures DNA from a ... assessment of the state of a man,s disease, a ... blood test could reveal when treatment for advanced ... growth, the researchers suggested. "Our study showed that ... cancer and often initially very effective started to activate ...
(Date:9/17/2014)... R.I. [Brown University] As Congress adjourns this month ... senators will step over on their way out the ... Repeal and Medicare Provider Payment Modernization Act of 2014. ... Surgery , Dr. Eli Adashi recounts what he and ... bipartisan bill. The perennial trouble with how Medicare pays ...
Breaking Medicine News(10 mins):Health News:Social Networking Sites Can Help Obese Lose Weight: Study 2Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 2Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 3Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 4Health News:New OptiPact™ Technology Introduced by Catalent 2Health News:DNA Blood Test Might Identify Status of Prostate Cancer 2Health News:Failed Medicare payments law remains relevant 2Health News:Failed Medicare payments law remains relevant 3
... ... Enter Three Year GPO Agreement , ... Wichita, KS (PRWEB) October 26, 2009 -- MedAppz, a leading provider ... Chain Systems, today announced a multiyear agreement to offer EHR software as a service ...
... Disproportionate impact ... is ticking for tens of thousands of heart patients in rural America as a looming ... cardiac care. , ... MI (PRWEB) October 26, 2009 -- The clock is ticking for tens of thousands of ...
... 26, 2009 A discovery by scientists at the Oklahoma ... injuries like those sustained in car crashes or on the ... diseases and diabetes. In a paper published online today ... Medicine , OMRF researcher Charles Esmon, Ph.D., with co-authors Florea ...
... are of particular note in today,s Scientific Program ... of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology ... exam clues that should make ophthalmologists suspect an atypical ... Singapore National Eye Center study that diabetics who are ...
... suggests they,re more susceptible to dangers of tobacco , SUNDAY, ... than men to the carcinogens and other noxious substances in ... one study of nearly 700 people with lung cancer, Swiss ... received the diagnosis, even though they smoked less than the ...
... Oct. 24, 2009 Born with a retinal disease that ... sightless, the nine-year-old boy used to sit in the back ... electronic screen and assisted by teacher aides. Now, after a ... back of his eye, he sits in front with classmates ...
Cached Medicine News:Health News:MedAppz Signs Agreement with MedAssets to Offer SAAS-based Electronic Health Record to MedAssets' Non-acute Customers 2Health News:Cardiac Patients Across Rural America Risk Losing Access to Nearby Care as Federal Agency Considers Cuts this Week 2Health News:Cardiac Patients Across Rural America Risk Losing Access to Nearby Care as Federal Agency Considers Cuts this Week 3Health News:Oklahoma scientists discover promising new path for treating traumas 2Health News:Clues to visual variant Alzheimer's; myopia and diabetic retinopathy risk 2Health News:Clues to visual variant Alzheimer's; myopia and diabetic retinopathy risk 3Health News:Is Smoking Tougher on Women? 2Health News:Is Smoking Tougher on Women? 3Health News:1 shot of gene therapy and children with congenital blindness can now see 2Health News:1 shot of gene therapy and children with congenital blindness can now see 3Health News:1 shot of gene therapy and children with congenital blindness can now see 4Health News:1 shot of gene therapy and children with congenital blindness can now see 5
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: